Kolexia
Monjanel Helene Oncologie hémato.
Monjanel Helene
Oncologie hémato.
Ch Henri Mondor
Aurillac, France
51 Activités
0 Followers
Scientifique
Digital
Production scientifique
Activités par an
Expertise
Sujets de recherche
{{person.topmesh1.name}} Lymphomes Maladie de Hodgkin Lymphome malin non hodgkinien Lymphome B Lymphome T Lymphome B diffus à grandes cellules Lymphome plasmoblastique Lymphome folliculaire Maladie des chaines lourdes

Collaborateurs

Voir plus
Gyan Emmanuel
Gyan Emmanuel
Centre hospitalier de Tours, Tours, France
Damaj Ghandi Laurent
Damaj Ghandi Laurent
Hôpital Côte de Nacre, Caen, France
Trouillier Sebastien
Trouillier Sebastien
Hôpital Gabriel Montpied, Clermont-Ferrand, France
Tilly Herve
Tilly Herve
Centre Henri-Becquerel, Rouen, France

Industries

Voir plus
Janssen
10 collaboration(s)
Dernière en 2023
Abbvie
2 collaboration(s)
Dernière en 2021
Sanofi
2 collaboration(s)
Dernière en 2022
Leo Pharma
1 collaboration(s)
Dernière en 2021

Dernières activités

Voir plus
Prevalence and diagnostic performance of iron deficiency in polycythemia.
Hematology (Amsterdam, Netherlands)   01 mai 2023
Listeria endocarditis and spondylodiscitis: A case report and review of the literature.
Clinical case reports   20 mai 2022
Outcomes after first-line immunochemotherapy for primary mediastinal B-cell lymphoma: a LYSA study.
Blood advances   01 novembre 2021
OUTCOMES AFTER FIRST-LINE IMMUNOCHEMOTHERAPY FOR PRIMARY MEDIASTINAL B CELL LYMPHOMA PATIENTS: A LYSA STUDY
16th International Conference on Malignant Lymphoma, Virtual Edition, 18–22 June, 2021   17 juin 2021
MONOMORPHIC EPITHELIOTROPIC INTESTINAL T-CELL LYMPHOMA (MEITL): CLINICO-PATHOLOGICAL ANALYSIS OF A MULTICENTER EUROPEAN COHORT
16th International Conference on Malignant Lymphoma, Virtual Edition, 18–22 June, 2021   17 juin 2021
044 | MONOMORPHIC EPITHELIOTROPIC INTESTINAL T-CELL LYMPHOMA (MEITL): CLINICO-PATHOLOGICAL ANALYSIS OF A MULTICENTER EUROPEAN COHORT
16th International Conference on Malignant Lymphoma, Virtual Edition, 18–22 June, 2021   09 juin 2021
050 | OUTCOMES AFTER FIRST-LINE IMMUNOCHEMOTHERAPY FOR PRIMARY MEDIASTINAL B CELL LYMPHOMA PATIENTS: A LYSA STUDY
16th International Conference on Malignant Lymphoma, Virtual Edition, 18–22 June, 2021   09 juin 2021
R-CHOP14 As a Standard of Care in Primary Mediastinal B Cell Lymphoma: A 10-YEARS Experience of Lysa Centers
Blood   05 novembre 2020
Nonlinear pharmacokinetics of rituximab in non-Hodgkin lymphomas: A pilot study.
British journal of clinical pharmacology   26 juin 2019
Complex target-mediated elimination of rituximab in non-Hodgkin's Lymphoma patients
Abstracts of the Annual Meeting of French Society of Pharmacology and Therapeutics, and INSERM Clinical Research Centers (CIC) Meeting, 12–14 June 2018, Toulouse, France   31 mai 2018